Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.3M Sell
466,383
-23,763
-5% -$4.31M 0.49% 36
2026
Q1
$72.1M Buy
490,146
+103,655
+27% +$16.8M 0.61% 28
2025
Q4
$75.3M Buy
386,491
+218,251
+130% +$52M 0.69% 28
2025
Q3
$47.3M Sell
168,240
-34,375
-17% -$8.75M 0.45% 44
2025
Q2
$44.3M Sell
202,615
-3,787
-2% -$612K 0.5% 37
2025
Q1
$28.9M Sell
206,402
-15,102
-7% -$2.46M 0.42% 50
2024
Q4
$36.9M Buy
221,504
+98,524
+80% +$17.5M 0.65% 31
2024
Q3
$21M Buy
122,980
+89,142
+263% +$12.9M 0.53% 36
2024
Q2
$4.78M Buy
33,838
+1,554
+5% +$193K 0.13% 147
2024
Q1
$4.06M Buy
32,284
+1,758
+6% +$201K 0.08% 243
2023
Q4
$3.22M Buy
30,526
+3,139
+11% +$343K 0.08% 269
2023
Q3
$2.9M Buy
+27,387
New +$3.17M 0.09% 236

Other funds holding ORCL

Vident Advisory's ORCL Position: Q2 2026 in Review

Vident Advisory reduced its Oracle (ORCL) stake by 4.8% in Q2 2026, selling an estimated $4.31M and leaving 466,383 shares worth $68.3M. The position accounts for 0.49% of the portfolio, ranked #36.

Vident Advisory first reported a position in ORCL in Q3 2023 and has held it in 12 quarters since. The position peaked at $75.3M in Q4 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Vident Advisory held 466,383 shares of Oracle worth $68.3M as of Q2 2026.
  • Vident Advisory sold 23,763 Oracle shares in Q2 2026, an estimated $4.31M.
  • Oracle made up 0.49% of Vident Advisory's portfolio in Q2 2026, its #36 holding.
  • Vident Advisory first reported a position in Oracle in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's Oracle position peaked at $75.3M in Q4 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.